RxDoctor Payments DataLook up a doctor →

Ahtesham Ali

Acute Care · El Paso, TXNPI 1356988117

Payments from drug & device makers

$14,051in general payments, 2019–2025

Across 547 payments — averaging $25.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Biogen$1K
  • Neurocrine Biosciences, Inc.$1K
  • UCB, Inc.$1K
  • AbbVie$917
  • Argenx US, Inc.$623
  • plus $7K from 34 others

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,051 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas

Medicare billing

Part B allowed, 2024
$25,068
Medicare patients
116
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in El Paso

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →